000 | 01791 a2200517 4500 | ||
---|---|---|---|
005 | 20250517000118.0 | ||
264 | 0 | _c20150626 | |
008 | 201506s 0 0 eng d | ||
022 | _a1757-4684 | ||
024 | 7 |
_a10.15252/emmm.201403967 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMojumdar, Kamalika | |
245 | 0 | 0 |
_aInflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2. _h[electronic resource] |
260 |
_bEMBO molecular medicine _cNov 2014 |
||
300 |
_a1476-92 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Ly _xanalysis |
650 | 0 | 4 |
_aCD11b Antigen _xanalysis |
650 | 0 | 4 |
_aChemokine CCL2 _xmetabolism |
650 | 0 | 4 |
_aDiaphragm _xpathology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMesenchymal Stem Cell Transplantation |
650 | 0 | 4 |
_aMesenchymal Stem Cells _xmetabolism |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Inbred mdx |
650 | 0 | 4 |
_aMonocytes _xchemistry |
650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _ximmunology |
650 | 0 | 4 |
_aMutant Proteins _xmetabolism |
650 | 0 | 4 |
_aReceptors, CCR2 _xantagonists & inhibitors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLiang, Feng | |
700 | 1 | _aGiordano, Christian | |
700 | 1 | _aLemaire, Christian | |
700 | 1 | _aDanialou, Gawiyou | |
700 | 1 | _aOkazaki, Tatsuma | |
700 | 1 | _aBourdon, Johanne | |
700 | 1 | _aRafei, Moutih | |
700 | 1 | _aGalipeau, Jacques | |
700 | 1 | _aDivangahi, Maziar | |
700 | 1 | _aPetrof, Basil J | |
773 | 0 |
_tEMBO molecular medicine _gvol. 6 _gno. 11 _gp. 1476-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.15252/emmm.201403967 _zAvailable from publisher's website |
999 |
_c24275903 _d24275903 |